Skinvisible (SKVI) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2019)
Powered by 
Analysis
Skinvisible (SKVI) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2019) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.12 Bn | 626.36 Bn | 17.26 Bn | 7.44% |
| 2 | AbbVie | 440.93 Bn | 434.36 Bn | 12.70 Bn | 9.71% |
| 3 | Merck | 364.34 Bn | 357.20 Bn | 12.21 Bn | 1.99% |
| 4 | Novartis Ag | 268.31 Bn | 260.62 Bn | 11.24 Bn | 2.94% |
| 5 | Pfizer | 158.49 Bn | 146.79 Bn | 10.94 Bn | 1.35% |
| 6 | Sanofi | 52.52 Bn | 45.14 Bn | 10.79 Bn | 13.89% |
| 7 | Revolution Medicines | 44.27 Bn | 44.27 Bn | - | - |
| 8 | Incyte | 25.01 Bn | 20.47 Bn | 1.57 Bn | -11.15% |
| 9 | United Therapeutics | 21.18 Bn | 18.51 Bn | 683.80 Mn | 41.67% |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | -80.00% |
| Dec 31, 2018 | -67.13% |
| Sep 30, 2018 | -59.77% |
| Jun 30, 2018 | -54.70% |
| Dec 31, 2017 | -47.44% |
| Jun 30, 2017 | -42.43% |
| Dec 31, 2016 | -59.71% |
| Jun 30, 2016 | -63.58% |
| Mar 31, 2016 | -54.86% |
| Dec 31, 2015 | -48.24% |
| Sep 30, 2015 | -43.05% |
| Jun 30, 2015 | -13.81% |
| Mar 31, 2015 | -10.53% |
| Dec 31, 2014 | -7.88% |
| Sep 30, 2014 | -5.68% |
| Jun 30, 2014 | -31.80% |
| Mar 31, 2014 | -29.45% |
| Dec 31, 2013 | -20.27% |
| Sep 30, 2013 | -18.50% |
| Jun 30, 2013 | -16.92% |